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The genetic modification of crop plants from the methodology involved in their
production through to the current debate on their use in agriculture are
reviewed. Techniques for plant transformation by Agrobacterium tumefaciens
and particle bombardment, and for the selection of transgenic plants using
marker genes are described. The benefits of currently available genetically
modified (GM) crops in reducing waste and agrochemical use in agriculture, and
the potential of the technology for further crop improvement in the future are
discussed. The legal requirements for containment of novel GM crops and the
roles of relevant regulatory bodies in ensuring that GM crops and food are safe
are summarized. Some of the major concerns of the general public regarding
GM crops and food: segregation of GM and non-GM crops and cross-pollination
between GM crops and wild species, the use of antibiotic resistance marker
genes, the prevention of new allergens being introduced in to the food chain
and the relative safety of GM and non-GM foods are considered. Finally, the
current debate on the use of GM crops in agriculture and the need for the
government, scientists and industry to persevere with the technology in the face
of widespread hostility is studied.
What is genetic modification?
Plant genetic modification (also known as genetic engineering) may be
defined as the manipulation of plant development, structure or
composition by the insertion of specific DNA sequences. These sequences
may be derived from the same species or even variety of plant. This may
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animals or microbes, and the aim is to introduce novel biological
properties or activities.
Farmers and plant-breeders have been changing the genes of crop
plants for thousands of years. However, genetic modification differs
from conventional plant breeding in the precision of gene transfer.
Conventional breeding is based on the crossing of genotypes containing
literally tens of thousands of expressed genes and the selection of
progeny that combine the best features of the two parents. In some cases
the progeny may contain almost equal numbers of genes from each
parent. In others, an attempt may be made to incorporate a single gene
from parent a into parent b by production of a hybrid followed by
repeated backcrossing with parent b and selection of a desired trait over
many generations. However, even after repeated backcrossing, it is
inevitable that many undesired genes will also be transferred, and it is
almost impossible to identify all of these and their products.
Conventional breeding is limited by fertility barriers that allow only
plants of the same, or closely related, species to be crossed. However,
'wide crossing' with more distantly related species can be achieved if
'embryo rescue' is used to culture and regenerate embryos that would
normally abort. Similarly, mutagenesis with chemical or physical
mutagens can be used to induce new variation in the species of interest.
Both wide crossing and mutation breeding can result in the expression
in crop plants of many novel or modified genes, the effects of which
cannot be assessed readily. However, both approaches are considered to
be 'conventional', with no requirement for detailed assessment of the
plants produced before they are introduced into the food-chain.
DNA delivery and selection of transgenic plants
Plant transformation can be divided broadly into two stages: DNA
delivery and plant selection and regeneration. Two methods are widely
used to deliver DNA into plant cells. The first
1 exploits nature's own
genetic engineer, the naturally occurring soil bacterium Agrobactenutn
tumefaciens, which infects wounds on some plants to form a tumourous
growth called a 'crown gall'. The tumour formations (Fig. 1A) result
from integration of a DNA fragment (the T-DNA) from the
Agrobactenum into the plant genome. As well as inducing tumour
growth, genes present in the T-DNA cause the tumourous cells to
produce compounds on which the bacteria feed. The T-DNA is present
in a plasmid (the Ti or tumour-inducing plasmid), a closed circle of
extra-chromosomal DNA, rather than the bacterial chromosome. This
means that it can be isolated and manipulated to remove the genes that
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would be inserted into a plant by wild Agrobactenum and replace them
with novel genes. After infection of plant material with the modified
Agrobacterium, whole plants can be regenerated from the resulting
genetically modified tumour-like cell clumps (callus) by application of
plant hormones.
The second widely used method is particle bombardment, in which the
DNA is coated onto the surface of microscopic gold particles which are
then shot into plant cells using a burst of helium gas. Some of the DNA
is washed off the particles and becomes integrated into the plant genome
(Fig. 1C,D). As with the first method, whole plants can be regenerated
from genetically modified cells by careful culturing and the application
of plant hormones. This method, which has acquired the unfortunate
name of biohstics, has been particularly successful in the production of
genetically modified cereals
2.
A current limitation to plant genetic modification is that only some of
the cells in the target tissue are genetically modified, irrespective of the
method of transfer. It is, therefore, necessary to kill all of the cells that
are not modified and this requires that the gene of interest be
accompanied by at least one other gene that acts as a selectable marker.
In practice, this is usually a gene which makes the transformed cells
resistant to an antibiotic (e.g. kanamycin; Fig. IB) or herbicide (e.g.
phosphinothricin, the active ingredient of Basta; Fig. 1C) which is toxic
to untransformed cells. The use of antibiotic resistance genes is discussed
further below, but the presence of a selectable marker gene is currently
the minimum requirement for plant transformation. A scoreable marker
gene may also be present to allow the transformed cells to be visualised,
and the bacterial UtdA (gus; Fig. ID) or the jellyfish green fluorescent
protein (GFP) genes
3'
4 may be used for this. However, the presence of
these genes is not essential and it is accepted that they should be avoided
when producing transgenic plants for food or animal feed.
Benefits of GM crops currently in commercial production and
future prospects
The UK is a world leader in this technology, but at present the growing of
genetically modified (GM) crops is limited to a few selected test sites. In
comparison, 49 million acres of GM crops were planted in the US alone
in 1998. However, three imported products from GM crops grown
commercially elsewhere in the world have been approved for food use in
the UK: slow-ripening tomatoes; soya that is tolerant of a broad-range
herbicide (weedkiller) called glyphosate; and insect-resistant maize.
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The tomatoes are used to make tomato paste, reducing waste and
processing costs, and 2 million tins of clearly labelled GM tomato paste
have been sold in the UK since its mtroduaion in 1996. It has a clear con-
sumer benefit in that it is cheaper than its non-GM competitors and of a
thicker consistency. Glyphosate-tolerant crops enable farmers to use a
Fig. 1 Introduction of foreign DNA into plant
tissue and the selection of genetically
modified plants. (A) Undifferentiated
(tumourous) potato callus tissue produced by
infection of leaf discs with Agrobacterium
tumefaciens. Some of the tissue is producing
shoots in response to the application of a
plant shoot-inducing hormone. (Picture
courtesy of Patrick Purcell.). (B) Selection of
transgenic plants containing an antibiotic
resistance marker gene The genetically
modified tobacco plant (right) is thriving in
the presence of kanamycin, whereas the
unmodified control (left) is bleaching and
dying. (C) Selection of transgenic plants
containing a herbicide-tolerance marker gene.
Unmodified wheat plants are shown in the
absence (left) and presence (middle) of the
herbicide Basta. A genetically modified wheat
plant growing in the presence of the herbicide
is shown on the right (Picture courtesy of Pilar
Barcelo.). (D) Wheat embryos showing
expression of the scoreable marker gene UidA
(gus) after its introduction by particle
bombardment The genetically modified cells
make an enzyme that produces a blue product
from a substrate present in the medium.
(Picture courtesy of Sophie Laurie)
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single, safe, rapidly-degrading herbicide instead of a battery of more expen-
sive, more poisonous and more persistent herbicides, reducing total
herbicide use by almost half in some cases
5. They also allow farmers to use
no-till agriculture, leaving the soil and weed cover undisturbed over winter,
greatly reducing soil erosion and loss of groundwater, as well as providing
habitats for insects and birds. Herbicide tolerant soya made up half of the
US and 70% of the Argentine crop in 1998, and is popular with farmers
throughout the Americas. However, the lack of a clear benefit to the
consumer and the widespread, erroneous belief that use of herbicide
tolerant varieties would lead to an increase in the amounts of herbicide
being applied has made consumer acceptance difficult to achieve in the UK.
The maize approved for food use in the UK contains a gene
(commonly called the bt gene) from a bacterium, Bacillus thuringiensis.
The protein produced by this gene is toxic to some insects, mainly
caterpillars, and the bacteria themselves have been used as an insecticide
by organic farmers for decades. Variants of the bt gene have been
introduced into several crops grown in the US
6, including cotton, sugar
beet and potato, as well as maize. The effect of its use in cotton has
perhaps been the most striking. Conventional cotton is very susceptible
to insect damage and one quarter of US insecticide production is used on
this one crop, including 'hard', persistent and completely unselective
insecticides such as organophosphates. GM cotton on average requires
15% of the insecticide used on conventional cotton and in some areas of
the US in 1996-1998 was not sprayed with insecticide at all. The bt
protein does not affect bees or many other bemgn insects, and has no
toxicity to mammals, birds or fish.
A recent study found that caterpillars of the monarch butterfly (which
is not a pest species) that were forced under laboratory conditions to eat
large quantities of pollen from bt maize (they would not normally eat
pollen) suffered higher mortality levels than caterpillars that were not
fed the pollen
7. However, it should be remembered that spraying
caterpillars and other insects with pesticide, which equates with the
regimen used in the field for almost all non-GM maize, kills them all
outright. Use of 'hard' pesticides, such as organophosphates, has been
reduced greatly or eradicated altogether with the introduction of GM
varieties.
These crops represent the first generation of GM plants in agriculture,
but there are many other targets for crop biotechnology. These include
other agronomic traits, such as virus resistance
8 and new quality
attributes such as nutritional value, including levels of vitamins and
other micro-nutrients, such as iron, iodine and folate, as well as colour
and flavour. Crops will soon be available that contain modified oils
9,
either tailored to meet the specific requirements of processors, or with
pharmaceutical
1
0 or other industrial uses, such as the production of
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biodegradable plastics. The use of genetic modification to improve the
bread-making quality of UK wheat varieties (UK and European wheats
are poor in this respect) is already well advanced
1
1 and wheat, potato
and maize are also being modified to produce starch for industrial uses.
Other non-food targets include pharmaceuticals, fragrances, pigments
and safe, cheap, edible vaccines
12. The latter have already reached the
human testing stage for vaccines against diarrhoea Escherichta coli and
hepatitis B, and is obviously most relevant to those areas of the world
where drugs, clean needles and syringes are not readily available.
Containment, safety assessment and the role of regulatory
authorities
While recognising that GM technology is already benefiting agriculture
elsewhere in the world and that the potential benefits of the technology in
the UK justify supporting and investing in it, the government, scientists
and industry are aware that, as with all new technologies that impact
upon the environment and consumer, it should be introduced carefully.
For this reason, any organization that seeks to use genetic modification,
even in contained conditions, must first obtain approval from the Health
and Safety Executive (HSE)
13-
14. A successful application requires that the
facilities meet certain standards to ensure that GM organisms are
contained, that procedures are in place for sterilization of GM material,
and that there is sufficient experience in handling potentially hazardous
biological material amongst the staff. Typically GM plants are kept in a
greenhouse with filtered negative air pressure ventilation, sealed drains
and a chlorination treatment system for drainage water.
There is also a legal requirement for the organization to assess, before
beginning a GM project, whether the plants that will be produced could
represent a risk to humans, other plants or the environment, including the
chances and consequences of cross-pollination with other plants. The HSE
inspects organizations regularly to ensure that this assessment process is
being carried out satisfactorily.
Before any GM plants can be planted outside of a containment facility
in the UK, permission has to be granted by the Department for the
Environment, Transport and Regions (DETR)
15-
16. Applications are
considered by the Advisory Committee for Release mto the Environment
(ACRE), an independent committee of experts who consider a similar set
of questions on the safety of GM crops to those detailed above, on a case-
by-case basis. As well as a detailed risk assessment, the Committee has
available the data on the genetic stability and performance of the crop,
obtained under contained conditions, usually over several years prior to
release.
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Assessment of the safety of GM foods is undertaken in the UK by the
Advisory Committee on Novel Foods and Processes (ACNFP), another
independent committee of experts, with members from universities and
research institutes. Any GM food, no matter where it is produced, must
be approved by this Committee before it is permitted to enter the UK
food-chain. ACNFP requires that information be provided on the
composition of materials, effects of production, stability, nutritional
characteristics and the likelihood of genetic transfer. It has been argued
that GM foods should be subjected to the same testing and approval
procedures as medicines (i.e. clinical trials). The Government's view,
which we share, is that this is impractical and that the methods
recommended by the World Health Organization
17'
1
8 are adequate to
ensure that any possibility of an adverse effect on human health from a
GM food can be detected.
Public concerns
Segregation of GM and non-GM crops and the environmental impact of cross-pollination
between GM crops and wild species
Unless GM food is accepted universally, which seems unlikely in the
foreseeable future, it is important that alternatives remain available to
allow consumers to exercise choice. For imported food-stuffs, UK
suppliers will have to contract farmers overseas to grow non-GM
varieties. This means paying a guaranteed price to a farmer to use old-
fashioned varieties and high chemical inputs. The additional cost will be
passed on to the consumer and non-GM soya is already 40% more
expensive than the GM alternative. For crops grown in the UK, the main
issue will be segregation of GM and non-GM crops and food. Segregation
could break down through accidental mixing of GM and non-GM seed
for planting, by cross-pollination between GM and non-GM crops (which
is less of a problem for inbreeding species such as wheat) or by mixing of
the product between the farm gate and the consumer. Some inadvertent
mixing is almost inevitable and the production of certifiably GM-free
food is, therefore, likely to be expensive. Clearly, a farmer who had paid
for expensive GM seed in order to produce a high-value product would
wish to avoid pollination from a nearby non-GM crop, and segregation is
likely to be a subject of considerable dispute.
The potential environmental impact of cross-pollination with wild
species has to be assessed case-by-case, taking into account the species
and genes involved. Wheat, maize and potato, for example, do not cross
with any wild species in the UK (although forced crosses can be made
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between potato and black nightshade in the laboratory). Sugar beet
crosses with wild and weed beet, but this poses little threat to agriculture.
Indeed, the only major crop in which cross-pollination could be a problem
is oilseed rape. This will cross with other cultivated and wild Brassicas,
including Chinese cabbage, Brussels sprouts, Indian mustard, hoary
mustard, wild radish and charlock. The extent of such crossings in
agricultural systems is the subject of continuing research, but it does not
necessarily mean that GM oilseed rape represents a threat, as this will also
depend on whether the gene involved could confer a competitive
advantage on a plant that acquired it. The issue of cross-pollination with
wild species is reviewed in more detail by Raybould
19.
Antibiotic resistance marker genes
Another topic that has generated much debate, some of it wildly
overblown, is the use of antibiotic resistance genes as selectable markers.
The use of marker genes to select cells that have been modified with
genes of interest is discussed above, and antibiotic resistance genes have
been extremely valuable in the development of GM technology. Many
scientific bodies around the world, including the World Health
Organization and regulatory committees set up by the European Union
and several national governments have considered the safety of
antibiotic genes in food and have concluded that those that are being
used do not represent a health threat. The British Medical Association,
however, has expressed reservations
20, and the ACNFP has called for the
development of alternative marker systems
21.
The main reason for believing that antibiotic resistance genes in GM
crops do not represent a health threat is that they already occur in
natural microbial populations, indeed they are widespread amongst soil
bacteria
22. Those that are used most frequently confer resistance to
antibiotics that are not used at all in oral medical formulations, such as
kanamycin and neomycin, although one notable exception to this is the
insect-resistant GM maize of Novartis, which contains a gene for
resistance to ampicillin. Further re-assurance can be taken from the fact
that horizontal transfer of a gene from ingested plant material to
bacteria has never been demonstrated, and there is no indication that it
has ever occurred during evolution. The probability that it could occur
is, therefore, considered to be so low that it is not relevant when
compared with the natural occurrence of antibiotic resistance genes.
Antibiotic resistant strains of pathogenic bacteria do represent a health
threat, but they arise naturally and thrive because of the sloppy
management of antibiotics in human and animal medicine, not because
of the use of antibiotic resistance marker genes in biotechnology.
British Medical Bulletin 2000,56 (No 1) 69Health and the food-chain
Allergenicity
Gene introduced
from allergenic
source
Gene introduced
from non-
allergenic
source
It has been suggested that consumption of GM foods could lead to
increases in toxicity and allergenicity. This is particularly relevant to the
use of protective proteins to confer resistance to pests and pathogens as
these can reasonably be expected to also show some toxicity to humans.
In addition, there was a widely reported case where a methionine-nch
2S albumin storage protein from Brazil nut was expressed in soybean in
order to increase the methionine content for animal feed
23. The protein
was subsequently shown to be an allergen, as are a number of related 2S
albumins from other species. The plant breeding programme was,
therefore, discontinued as it would be difficult to guarantee that the GM
soya would not enter the human food chain. This case certainly
illustrates the potential for introducing allergens and toxins by genetic
modification. However, the fact that the problem was identified before
commercial material was produced, and appropriate action taken,
demonstrates the high level of awareness of such problems in the plant
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Fig. 2 Flow diagram showing the assessment and testing of possible allergenicity in GM foods. Redrawn from
Astwood et aP*, with the publisher's permission
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biotechnology industry and the effectiveness of 'in house' screening
programmes. A typical procedure used to test for the presence of food
allergens in transgenic plants is summarized in Figure 2, while the
application of this procedure to the GM soybeans containing the Brazil
nut 2S albumin is described by Nordlee et aP
3. The biotechnology
industry takes the view that release of new allergenic products into the
food chain is entirely avoidable
2
4 and the legal requirements for feeding
trials provide an additional, effective safety net. Consequently, GM
foods may well prove to be safer than those produced by conventional
plant breeding, as discussed below.
Relative safety of GM foods compared with 'traditional' foods
The major arable and horticultural crops grown and consumed in
Western Europe have been developed using conventional breeding
methods, often over centuries or even millennia. Consequently, they are
assumed by the consumer to be safe and wholesome. However, most, if
not all, of these crops contain compounds that are potentially toxic or
allergenic. In most cases, these compounds have probably evolved to
provide protection against animal predators or pathogenic micro-
organisms and it is, therefore, not surprising that they are also toxic to
humans. Furthermore, they are particularly abundant in seeds and
tubers, whose rich reserves of proteins, starch and oil are particularly
attractive to pests and pathogens. Well-known examples are glyco-
alkaloids in potatoes, cyanogenic glycosides in linseed, glucosinolates in
Brassica oilseeds and proteinase inhibitors in soybean and other legume
seeds. It is very doubtful whether these, or many other generally accepted
foods, would be approved for food use were the toxins introduced by
genetic modification. Similarly, the introduction of new types and varieties
of food crops produced by conventional breeding requires no specific
testing for the presence of allergens and toxins, although genes may have
been introduced from exotic varieties or related wild species. Toxins can
also be produced by fungal activity before harvesting or during storage.
Ironically, these mycotoxins, including dangerous carcinogens such as
aflotoxin, are particularly prevalent in organic food, which has not been
treated with fungicides.
It is clear that the public requires a higher level of assessment of the
safety of GM food than conventional or organic foods and this is only
possible because genetic modification is such a precise process. The
products of the introduced genes are readily identified and their
expression levels determined. The products may also be isolated in a pure
form, either from the species of origin, from the transformed plant or after
expression in a micro-organism. The pure protein can then be tested in
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detail and its presence in processed foods monitored. In contrast, it is
virtually impossible to identify and characterize the changes in food
composition that may result from conventional plant breeding.
Consequently, we would argue that GM foods may be safer than food
derived from non-GM varieties as the risks are readily quantified and
monitored and GM foods are examined under a rigorous assessment
system that goes beyond that applied to other foods.
Concluding remarks
Despite the safeguards applied to GM crops and foods, and the clear
benefits that they are bringing, public acceptance in the UK is currently
low. There are several reasons for this, including unease about food
safety in general, caused by factors (BSE, E. coli, Salmonella, etc) that
have nothing to do with GM, lack of information on the benefits, a well-
organized anti-GM campaign lead by professional, multinational
pressure groups (who have no responsibility for food production), and
a succession of wild scare-stories. Much of the debate revolves around
products that are not, and may never be, commercially available, the
infamous 'terminator' crops and tomatoes containing fish genes being
good examples. The industry itself must also accept much of the blame
for public hostility, since the lack of labelling of GM products between
late 1996 and 1999 led to the perception amongst the public that the
technology was being imposed on them.
Governments continue to support research and development in plant
biotechnology in the face of this hostility, and there are strong arguments
to support this position. The most obvious is that GM crops are now well-
established and very successful in large areas of the world, particularly the
Americas and China, and other European countries are spending heavily
in order to catch up with the UK and US in the science. GM crops are
already playing a part in increased yields, improving nutritional quality,
increasing the profitability of agriculture and reducing its dependence on
high chemical inputs. It is almost inconceivable that this revolution in
agriculture could be reversed at this late stage. Sooner or later, we will
have to allow UK farmers to grow GM varieties if they are to compete.
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